Hospitals lose visibility into a large internal attack surface, and attackers can use unmanaged devices as quiet pivot points into EHR, directory, and backup systems. The control failure is not only patching. It is the absence of inventory, segmentation, and safe validation for assets that cannot be governed like standard endpoints.
Why Medical Devices Break Security Boundaries When They Are Left Out
Medical devices are not just another endpoint class. They often run long-lived software, have vendor-specific maintenance paths, and sit on flat networks that were designed for clinical uptime rather than security inspection. When governance excludes them, security teams lose the ability to decide what they are, where they belong, and how they should be controlled.
That gap matters because the device becomes part of the trust fabric by default, even if no one has formally accepted that risk. A device without an owner, inventory record, or segment assignment is effectively exempt from normal control decisions, which creates a blind spot in both routine operations and incident response.
How Attackers Turn Unmanaged Devices into Internal Pivot Points
Unmanaged devices are attractive because they often have weak validation, limited logging, and permissive connectivity to clinical or back-office systems. If a device can reach EHR services, directory services, or backups, it can become a quiet bridge into assets that matter more than the device itself. NHIMG’s Healthcare Identity Security Guide covers why shared clinical environments and medical-device access are often the real control boundary.
Devices also create a supply of embedded trust that attackers can abuse. A default credential, a stale service token, or a vendor remote-access path can be enough to blend in with normal traffic, especially when the environment lacks segmentation and inventory discipline. For connected devices, Device and IoT Identity Guide is the clearest NHIMG reference for onboarding, attestation, and trust decisions that keep device access bounded.
What Security Governance Has to Cover for Medical Devices
security governance for medical devices has to start with lifecycle ownership, not just patch management. The key questions are whether the asset is discovered, who approves its placement, what network zone it occupies, how it is validated before production use, and what evidence exists that the device is still within policy. In practice, governance fails when these answers are missing or scattered across biomedical engineering, IT, and clinical operations.
Validation also has to match device reality. Some devices cannot be patched on the normal enterprise schedule, some cannot tolerate aggressive scanning, and some require vendor support windows to stay safe. That means the control model must include approved compensating controls such as segmentation, allowlisting, monitored remote access, and change control that respects patient safety without surrendering visibility.
Risk and Threat Considerations
When medical devices sit outside security governance, the main risk is not only exploitability, but uncontrolled reach. A device that is not inventoried or segmented can become a persistence point, a lateral-movement path, or a backup target, and those paths are especially dangerous because they often bypass the controls applied to standard endpoints.
Failure mechanism: The organisation cannot enforce ownership, network placement, validation, or lifecycle review, so the device inherits trust without being proven trustworthy.
Impact: Attackers can use the device to move deeper into clinical and administrative systems, while defenders may not notice the compromise until the blast radius is much larger.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST CSF 2.0, CIS Controls v8 and NIST SP 800-53 Rev 5 set the technical controls, while ISO/IEC 27001:2022 defines the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST CSF 2.0 | ID.AM-01 — Physical devices and systems are inventoried | Medical devices must be inventoried before they can be governed. |
| PR.AA-05 — Assets are protected by controlled access | Segmentation and access restrictions are central to limiting device reach. | |
| DE.CM-09 — Network monitoring for anomalous events is performed | Unmanaged devices require monitoring to detect pivoting and misuse. | |
| Recommendation — Inventory all medical devices and keep ownership and location records current. Enforce access restrictions and network segmentation for medical devices. Monitor medical device traffic for unexpected lateral movement and access. | ||
| CIS Controls v8 | CIS-1 — Inventory and Control of Enterprise Assets | Discovery and asset inventory are foundational for governing medical devices. |
| CIS-12 — Network Infrastructure Management | Segmentation and controlled pathways reduce pivot risk from devices. | |
| Recommendation — Maintain an accurate inventory of all medical devices and their owners. Segment medical devices from higher-value clinical and administrative systems. | ||
| NIST SP 800-53 Rev 5 | CM-8 — System Component Inventory | Medical devices need formal inventory to support governance and risk decisions. |
| AC-4 — Information Flow Enforcement | Information flow controls are needed to constrain device-to-system reach. | |
| SI-4 — System Monitoring | Monitoring is needed to detect abnormal device behavior and pivoting. | |
| Recommendation — Record medical devices in a maintained system component inventory. Use information flow controls to restrict medical device communications. Monitor medical device activity for anomalous access and lateral movement. | ||
| ISO/IEC 27001:2022 | A.5.9 — Inventory of information and other associated assets | Medical devices must be identified as governed assets in the ISMS. |
| A.8.20 — Network security | Network security controls are required to isolate devices from sensitive systems. | |
| Recommendation — Include medical devices in the organisation’s asset inventory and ownership model. Apply network segregation and traffic controls to medical devices. | ||
Practitioner Guidance
What to prioritise: Start with inventory and network placement before you argue about patch cadence. If you cannot name the device, its owner, and its zone, you do not yet have a governance decision, only an assumption.
What to verify: Confirm that medical devices with any path to EHR, directory, or backup services are segmented, logged, and covered by an exception process that includes clinical ownership and a review date. NHIMG’s Healthcare Identity Security Guide is useful here because it treats medical-device access as part of the broader healthcare trust model, not as an isolated asset problem.
Decision rule: If a device cannot be tested or patched safely, treat segmentation, monitored access, and compensating controls as mandatory, not optional. The goal is not to make every device behave like a workstation, but to ensure the device cannot silently expand the attack surface.
Practitioner takeaway: The biggest failure is not that a medical device is old or constrained, it is that the organisation allows it to be connected without a governance model that limits where it can go and what it can reach.
Related resources from NHI Mgmt Group
- What is the difference between role-based access and API key governance for NHI security?
- How should security teams use IAST and RASP in NHI governance?
- Why is single-provider AI agent governance not enough for enterprise security?
- What breaks when medical devices are left outside normal security controls?
Deepen Your Knowledge
Free weekly newsletter
Subscribe to the NHI & AI Identity Journal
The latest on NHI and Agentic AI security – articles, research, breaches, news and events every week.
Bonus 33% off our NHI Course when you subscribe.
Reviewed and updated by the NHIMG editorial team on October 12, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org